NOïSIS Inc.  Canada

our mission

NOïSIS  addresses a global need for quantitative data-driven brain signal analysis.  Our aim is to build a medical service for diagnosing and monitoring neurological ailments by means of electro­physiological brain measures.

  1. Imaging-CRO :  comprehensive clinical research service for monitoring cognitive changes in clinical trials with EEG
  2. consultancy for study design
  3. protocols for data acquisition and brain stimulation
  4. partnership with leading EEG manufacturer for high-end FDA-approved EEG system
  5. data analysis and quantitative assessment

objectives

We are a R&D startup company focused on mapping the brain state.  Our initial emphasis is developing innovative approaches for longitudinal monitoring of cognitive integrity in multiple sclerosis and oncological chemotherapy.

  1. monitor neurological illness with brain EEG measures, an established, affordable and safe method
  2. assist pharmaceutical companies to expedite drug development in clinical trials; learn about mode of action
  3. objectively monitor cognitive outcome in clinical trials
  4. use real-life-like stimulus scenario
  5. detect and quantify beneficial or adverse treatment effects with data-driven analysis methods
  6. initial focus on multiple sclerosis and encephalopathy